Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E Kapiteijn
Targetable Gene Fusions Identified in Radioactive Iodine-Refractory Advanced Thyroid Carcinoma
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Thrombotic Microangiopathy With Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
Case Reports in Oncology
Oncology
Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) in Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid Carcinoma
JAMA - Journal of the American Medical Association
Medicine
Renal Dysfunction in Patients With Radioactive Iodine-Refractory Thyroid Cancer Treated With Tyrosine Kinase Inhibitors
Medicine
Medicine
RECIST 1.1 and Serum Thyroglobulin Measurements in the Evaluation of Responses to Sorafenib in Patients With Radioactive Iodine‑refractory Differentiated Thyroid Carcinoma
Oncology Letters
Cancer Research
Oncology
Radioactive Iodine Ablation May Not Decrease the Risk of Recurrence in Intermediate-Risk Papillary Thyroid Carcinoma
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Phase 2 Study Evaluating the Combination of Sorafenib and Temsirolimus in the Treatment of Radioactive Iodine-Refractory Thyroid Cancer
Cancer
Cancer Research
Oncology
P298 Thyroid Cancer Patient’s Fertility After Radioactive Iodine Therapy
Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That Is Refractory to Radioactive Iodine (RAI) Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
